Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:2569-2571
doi: 10.1161/CIRCULATIONAHA.106.629154
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kavey, R.-E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kavey, R.-E. W.
Related Collections
Right arrow Pediatric and congenital heart disease, including cardiovascular surgery
Right arrowRelated Article

(Circulation. 2006;113:2569-2571.)
© 2006 American Heart Association, Inc.


Editorial

Optimal Management Strategies for Patients With Complex Congenital Heart Disease

Rae-Ellen W. Kavey, MD, MPH

From the National Heart, Lung, and Blood Institute, Bethesda, Md.

Correspondence to Rae-Ellen W. Kavey, MD, MPH, National Heart, Lung, and Blood Institute, Bldg 31, Suite 4A10, Bethesda, MD 20892. E-mail kaveyr@nhlbi.nih.gov


Key Words: Editorials • heart defects, congenital • tetralogy of Fallot


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

The combination of critical pulmonary outflow obstruction with a large ventricular septal defect is symbolized by the diagnosis of tetralogy of Fallot, the most common form of cyanotic congenital heart disease. In many ways, the history of management for patients with tetralogy is representative of the evolution of management for all children with complex congenital cardiac diagnoses. Tetralogy was the first complex lesion addressed surgically with the palliative Blalock-Taussig shunt in 1945 and the first repaired completely with patients’ mothers serving as the bypass machine in 1954.1,2 The introduction of valved conduits in 1964 allowed repair of lesions not previously considered amenable to correction.3 The next 3 decades were marked by improved survival at open heart repair, recognition of the progressive deterioration of valved conduits necessitating early and repeated reoperation, and a progressive decrease in the age of primary repair to now the first few months of life.4,5 In the late 1970s, reports of arrhythmia and late sudden death among tetralogy survivors led to evaluation of tetralogy cohorts with residual right ventricular (RV) volume and/or pressure overload identified as predictors of late complications.6,7 Recognition of this problem heightened appreciation of the importance of arrhythmias in postoperative congenital heart disease patients and identified the need for informed long-term care and attention to residua of earlier procedures for all patients with congenital heart disease.8 Finally, the last 20 years have witnessed the dramatic rise in interventional procedures to address both correction of simple lesions and palliation/management of complex diagnoses.9

Article p 2598

. . . [Full Text of this Article]


Related Article:

Endovascular Stenting of Obstructed Right Ventricle–to–Pulmonary Artery Conduits: A 15-Year Experience
Lynn F. Peng, Doff B. McElhinney, Alan W. Nugent, Andrew J. Powell, Audrey C. Marshall, Emile A. Bacha, and James E. Lock
Circulation 2006 113: 2598-2605. [Abstract] [Full Text]